COVID-19 vaccine makers have contingency plans to deal with the Omicron variant that include a combination vaccine against the original version and the variant as well as a variant-specific booster dose, a top U.S. health official said on December 3.
If you are not happy with the results below please do another search
50 search results for:
Researchers from Harvard University and the U.S. Department of Veterans Affairs (VA) found that the Moderna mRNA vaccine was slightly better than the Pfizer-BioNTech vaccine.
Europe crossed 75 million coronavirus cases on December 3, according to a Reuters tally, as the region braces for the new Omicron variant at a time when hospitals in some countries are already strained by the current surge.
The U.S. Food and Drug Administration on December 3 authorized the use of Eli Lilly’s Covid-19 dual-antibody therapy in treating mild to moderate symptoms in all children, including newborns, who are at risk of severe illness.
Carmat on December 3 said the French medical device company suspended implants of the Aeson artificial hearts following a quality issue affecting some of its prostheses.
A sixth U.S. state – Nebraska – reported the Omicron variant of the coronavirus after detecting six confirmed cases of the highly contagious strain, the state’s health department said on December 3.
Scientists believe they have found the likely cause of blood clotting in some recipients of the Oxford-AstraZeneca Covid-19 vaccine.
The U.S. Securities and Exchange Commission filed insider trading charges against Usama Malik, the former chief financial officer of Immunomedics Inc.
BioSpace reviewed some of the more interesting scientific studies recently published, including research into a potential cause of Alzheimer’s disease and how deleting dysfunctional fat cells could alleviate diabetes.
BioNTech should be able to adapt the German company’s coronavirus vaccine relatively quickly in response to the Omicron variant, and the next few weeks will show how urgently an upgrade is needed, CEO Ugur Sahin told the Reuters Next conference on December 3.